Complementary and alternative medicine use among midlife women for reasons including menopause in the United States: 2002
National Center for Health Statistics/Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA. Menopause
(Impact Factor: 3.36).
03/2007; 14(2):300-7. DOI: 10.1097/01.gme.0000232031.84788.57
The use of complementary and alternative medicine (CAM) has been examined previously for midlife women only in regional studies. The purpose of this study was to obtain national estimates of CAM use.
Data were obtained from the 2002 National Health Interview Survey, which included a CAM supplementary questionnaire. The response rate was 74%. The analysis included 3,621 female respondents between 45 and 57 years of age who had answered all of the relevant questions. SUDAAN software was used to account for the complex sampling design.
Forty-five percent of women 45 to 57 years of age had used some form of CAM within the last 12 months. Approximately 25% used biologics (e.g., herbs) or mind-body (e.g., biofeedback) modalities, whereas only 15% used body work (massage and chiropractic medicine). Use did not vary by age, but white race, higher education, and residence in the West were associated with increased use. Only 45% of CAM users mentioned its use to a medical provider. The most cited reason for using CAM involved treatment of pain, with only 3% mentioning menopause. However, the odds for use of CAM were almost twice as high for women with menopausal symptoms in the past year compared with women with no symptoms (odds ratio: 1.9, 95% CI: 1.6-2.2).
CAM use among midlife U.S. women is high, although CAM is not used specifically for menopausal concerns. These data will be useful as a benchmark of the use of CAM as use of conventional menopause therapies are influenced by the Women's Health Initiative results.
Available from: ajol.info
- "In some researches with similar findings to ours, it was determined that 64.9% paid attention to their healthy diet (Gollschewski et al., 2005), 7.1% used nutrient tablets (Daley et al., 2006), 27% used multivitamin and calcium tablets (Kupferer, Dormire, Becker, 2009), 60.6% consumed phyto-oestrogen in their diets (Gollschewski et al., 2005). In the studies on using supplementary and alternative ways, it was observed that at menopausal age, consumption of soy bean included in phyto-oestrogen group was between 12.6% and 41.7% (Sluijs et al. 2007; Hill-Sakurai, 2008; Brett & Keenan 2007; Daley et al., 2006), and the use of phyto-oestrogen tablets was between 19% and 33% (Gollschewski et al., 2005; Kupferer, Dormire, Becker, 2009). Consequently, according to the findings it was determined that use of phyto-oestrogen tablets was higher, and the use of phyto-oestrogen in diets was lower in other researches. "
[Show abstract] [Hide abstract]
ABSTRACT: Millions of women experience menopause every year, therefore the aim of this study is to determine the rates of application of alternative methods applied by women in order to reduce their complaints caused by menopause and alternative application methods.
This study was carried out on 246 women in their menopausal period. The data was obtained by the researcher through face to face interviews during the home visits. During the collection of data, a questionnaire form by the researcher that was developed in accordance with the literature information was applied.
37.4% of women were determined to use alternative methods to reduce their menopausal symptoms. In the consequence of statistical analysis, a significant relation was found between the menopausal complaints such as hot flashes, night sweats and sleeping problem and the use of alternative methods in order to reduce their menopausal complaints (p<0.05).
It was determined that the women at their menopausal ages experienced vasomotor complaints and sleeping problems and they used alternative methods to reduce those problems.
African Journal of Traditional, Complementary and Alternative Medicines 07/2014; 11(2):295-300. DOI:10.4314/ajtcam.v11i2.12 · 0.56 Impact Factor
Available from: Masakazu Terauchi
- "Complementary and alternative medicines (CAM) are extensively used worldwide, especially by women, middle-aged individuals, and people with chronic diseases or poor overall health . In the early 2000s, approximately 50% of all middle-aged women in Western countries used CAM to alleviate menopausal symptoms [27, 28]. The current percentage may be even higher, considering the sustained decline in HT use among this population since the publication of the Women's Health Initiative results [29, 30]. "
[Show abstract] [Hide abstract]
ABSTRACT: Objectives. To identify the correlates of headaches in middle-aged women and investigate the effects of Tokishakuyakusan (TJ-23), a formula of traditional Japanese herbal therapy Kampo, on headache and concomitant depression. Methods. We examined cross-sectionally the baseline records of 345 women aged 40-59 years who visited our menopause clinic. Among them, 37 women with headaches were treated with either hormone therapy (HT) or TJ-23; the data of these women were retrospectively analyzed to compare the effects of the treatment. Results. The women were classified into 4 groups on the basis of their headache frequency, and no significant intergroup differences were noted in the physical or lifestyle factors, except age. Multiple logistic regression analysis revealed that the significant contributors to the women's headaches were their age (adjusted OR 0.92 (95% CI 0.88-0.97)) and their depressive symptoms (adjusted OR 1.73 (95% CI 1.39-2.16)). Compared to women treated with HT, women treated with TJ-23 reported relief from headaches (65% versus 29%) and concomitant depression (60% versus 24%) more frequently. Improvement in the scores of headaches and depression correlated significantly with TJ-23 treatment. Conclusions. Headache in middle-aged women is significantly associated with depression; TJ-23 could be effective for treating both of these symptoms.
Evidence-based Complementary and Alternative Medicine 02/2014; 2014(3):593560. DOI:10.1155/2014/593560 · 1.88 Impact Factor
Available from: Abbey Hyde
- "Nonetheless, the caution evident among participants in our study reflects more negative attitudes towards HT, and a decrease in HT-use in recent years (Lindh-Åstrand et al. 2007; Hoffmann et al. 2005). The interest in using alternative therapies to relieve menopause symptoms mirrors the findings of other studies across Western societies (Brett & Keenan 2007; van der Sluijs et al. 2007; Daley et al. 2006). "
[Show abstract] [Hide abstract]
ABSTRACT: The aim of this article was to explore women's experiences in biomedical consultations for menopause symptoms, with a particular focus on how hormone therapy (HT) featured during the encounter.
Semistructured interviews were conducted with 39 women, and data were analyzed using a qualitative strategy referred to as Thematic Networks.
Several participants whose menopause started before the period of the HT "scares" described being "put on" HT as a matter of course, even when their symptoms were mild. By contrast, some of those presenting in the more recent time period with what they deemed to be severe symptoms were more likely to describe scenarios whereby they pressured their physicians for an HT prescription. Once on HT, participants were found to be far from passive recipients of a biomedical "treatment" but rather embarked on an active dialogue with themselves about how to manage the distressing aspects of menopause.
Using HT did not tend to spell a transition to biomedical advocacy, despite its reported effectiveness in moderating bodily distresses. Rather, HT tended to retain a tentative status as a temporary relief and not a long-term panacea.
Menopause (New York, N.Y.) 03/2010; 17(2):344-50. DOI:10.1097/gme.0b013e3181c6b26f · 3.36 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.